Source: International Congress 2018 – Biomarkers in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Garudadri (Cleveland, United States of America), P. Woodruff (San Francisco, United States of America), M. Han (Ann Arbor, United States of America), R. Barr (New York, United States of America), E. Bleecker (Tucson, United States of America), R. Bowler (Denver, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), N. Hansel (Baltimore, United States of America), R. Paine (Salt Lake City, United States of America), J. Krishnan (Chicago, United States of America), S. Peters (Winston-Salem, United States of America), F. Martinez (New York, United States of America), J. Curtis (Ann Arbor, United States of America), A. Hastie (Winston-Salem, United States of America), W. O'Neal (Chapel Hill, United States of America), D. Couper (Chapel Hill, United States of America), N. Alexis (Chapel Hill, United States of America), S. Christenson (San Francisco, United States of America). Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS. 3580

Member's Comments

No comment yet.

Related content which might interest you: Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Determinants of heightened systemic inflammation at exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 115s Year: 2006 The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 283s Year: 2001 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Mechanisms of exacerbation of respiratory symptoms in patients with CHF Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Adherence with inhaled respiratory therapeutics is associated with reduced acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016